BMEA
Price
$12.51
Change
-$0.47 (-3.62%)
Updated
Apr 15, 6:59 PM EST
27 days until earnings call
INZY
Price
$4.71
Change
-$0.43 (-8.37%)
Updated
Apr 15, 6:59 PM EST
21 days until earnings call
Ad is loading...

Analysis and predictions BMEA vs INZY

Header iconBMEA vs INZY Comparison
Open Charts BMEA vs INZYBanner chart's image
Biomea Fusion
Price$12.51
Change-$0.47 (-3.62%)
Volume$442.38K
CapitalizationN/A
Inozyme Pharma
Price$4.71
Change-$0.43 (-8.37%)
Volume$489.71K
CapitalizationN/A
View a ticker or compare two or three
BMEA vs INZY Comparison Chart

Loading...

BMEADaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMEA vs. INZY commentary
Apr 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and INZY is a Hold.

COMPARISON
Comparison
Apr 16, 2024
Stock price -- (BMEA: $15.33 vs. INZY: $7.30)
Brand notoriety: BMEA and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 126% vs. INZY: 148%
Market capitalization -- BMEA: $550.18M vs. INZY: $450.94M
BMEA [@Biotechnology] is valued at $550.18M. INZY’s [@Biotechnology] market capitalization is $450.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 3 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • BMEA’s TA Score: 3 bullish, 6 bearish.
  • INZY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а +0.13% price change this week, while INZY (@Biotechnology) price change was +17.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.71%. For the same industry, the average monthly price growth was +6.49%, and the average quarterly price growth was +103.81%.

Reported Earning Dates

BMEA is expected to report earnings on May 13, 2024.

INZY is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BMEA with price predictions.
OPEN
A.I.dvisor published
a Summary for INZY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BMEA($550M) has a higher market cap than INZY($451M). INZY YTD gains are higher at: 71.362 vs. BMEA (5.579). INZY has higher annual earnings (EBITDA): -67M vs. BMEA (-124.62M). INZY has more cash in the bank: 189M vs. BMEA (177M). BMEA has less debt than INZY: BMEA (10.3M) vs INZY (46.6M). BMEA (0) and INZY (0) have equivalent revenues.
BMEAINZYBMEA / INZY
Capitalization550M451M122%
EBITDA-124.62M-67M186%
Gain YTD5.57971.3628%
P/E RatioN/AN/A-
Revenue00-
Total Cash177M189M94%
Total Debt10.3M46.6M22%
TECHNICAL ANALYSIS
Technical Analysis
BMEAINZY
RSI
ODDS (%)
N/A
Bearish Trend 15 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 15 days ago
86%
Bearish Trend 15 days ago
90%
Momentum
ODDS (%)
Bearish Trend 15 days ago
85%
Bullish Trend 15 days ago
88%
MACD
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 15 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 15 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 15 days ago
86%
Advances
ODDS (%)
Bullish Trend 26 days ago
83%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 15 days ago
90%
Aroon
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 15 days ago
84%
View a ticker or compare two or three
Ad is loading...
BMEADaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSSWX40.02N/A
N/A
JPMorgan Small Cap Sustainable Ldrs I
NWANX36.61N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc R6
CBLLX12.66-0.05
-0.39%
Allspring Large Cap Value Admin
FEQIX73.01-0.32
-0.44%
Fidelity Equity-Income
JIEMX20.10-0.09
-0.45%
JHancock Equity Income 1

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with VKTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+2.54%
VKTX - BMEA
47%
Loosely correlated
-2.99%
INZY - BMEA
37%
Loosely correlated
-4.70%
TERN - BMEA
37%
Loosely correlated
+8.23%
COGT - BMEA
35%
Loosely correlated
+2.68%
KROS - BMEA
30%
Poorly correlated
+1.28%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-4.70%
BEAM - INZY
51%
Loosely correlated
-1.09%
NTLA - INZY
49%
Loosely correlated
-1.05%
DNLI - INZY
43%
Loosely correlated
+0.29%
VCYT - INZY
43%
Loosely correlated
-2.35%
DAWN - INZY
41%
Loosely correlated
-2.06%
More